BIOTON S.A. (WSE:BIO)

Poland flag Poland · Delayed Price · Currency is PLN
4.220
+0.070 (1.69%)
Apr 16, 2026, 5:00 PM CET
Market Cap356.34M +12.9%
Revenue (ttm)282.52M +36.0%
Net Income3.39M
EPS0.04
Shares Out85.86M
PE Ratio105.06
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume23,703
Average Volume36,066
Open4.200
Previous Close4.150
Day's Range4.170 - 4.220
52-Week Range3.560 - 4.700
Beta0.23
RSI45.05
Earnings DateApr 29, 2026

About BIOTON

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1989
Employees 364
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BIO
Full Company Profile

Financial Performance

Financial Statements